Garfield Alastair
SEC CIK 2027261 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RYTM | RHYTHM PHARMACEUTICALS, INC. | CSO | 2,295 | — | $998.2K | 7 | 2025-07-01 | 2026-08-13 |
Most active insiders at RYTM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lee Jennifer Kayden | EVP, Head of North America | — | $8.90M |
| 2 | Smith Hunter C | CFO | — | $8.84M |
| 3 | Mazabraud Yann | EVP, Head of International | — | $6.62M |
| 4 | Meeker David P | Pres, CEO, Dir | — | $5.13M |
| 5 | TETRAULT LYNN A. | Dir | — | $3.71M |
| 6 | Shulman Joseph | Chief Technical Off | — | $3.67M |
| 7 | Cramer Pamela J. | CHRO | — | $2.99M |
| 8 | German Christopher Paul | CAO, Corp. Ctrl | — | $930.9K |
| 9 | Garfield Alastair | CSO | — | $912.7K |
| 10 | Arbuckle Stuart A | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-08-17 17:57 | 2026-08-13 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Garfield Alastair | CSO | S - Sale | $117.57 | -7,763 | 2,295 | -77% | -$912.7K |
| D | 2026-07-02 16:52 | 2026-07-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Garfield Alastair | CSO | M - OptEx | — | +4,445 | 12.2K | +57% | — |
| D | 2026-07-02 16:52 | 2026-07-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Garfield Alastair | CSO | F - Tax | $110.41 | -2,150 | 10.1K | -18% | -$237.4K |
| D | 2026-02-03 | 2026-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Garfield Alastair | CSO | M - OptEx | — | +6,663 | 9,789 | +213% | — |
| D | 2026-02-03 | 2026-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Garfield Alastair | CSO | F - Tax | $108.99 | -2,026 | 7,763 | -21% | -$220.8K |
| DM | 2025-07-03 | 2025-07-02 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Garfield Alastair | CSO | S - Sale+OE | $64.81 | -1,319 | 3,126 | -30% | -$85.5K |
| D | 2025-07-03 | 2025-07-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Garfield Alastair | CSO | M - OptEx | — | +4,445 | 4,445 | New | — |
Purchase Sale Sale after option exercise All abbreviations